Vaxigrip Trivalent Influenza Vaccine

Vaxigrip Trivalent Influenza Vaccine (split virion, inactivated) is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the influenza B virus type contained in the vaccine for active immunisation of adults, including pregnant women, and children from 6 months of age and older, and for passive protection of infants from birth to less than 6 months of age following vaccination of pregnant women.

The use of Trivalent Influenza Vaccine (split virion, inactivated) should be based on official recommendations.